Cited 116 times in
Long-Term Clinical Results of Tricuspid Valve Replacement
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강면식 | - |
dc.contributor.author | 유경종 | - |
dc.contributor.author | 임상현 | - |
dc.contributor.author | 장병철 | - |
dc.contributor.author | 홍유선 | - |
dc.date.accessioned | 2015-06-10T12:02:26Z | - |
dc.date.available | 2015-06-10T12:02:26Z | - |
dc.date.issued | 2006 | - |
dc.identifier.issn | 0003-4975 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/109082 | - |
dc.description.abstract | BACKGROUND: Tricuspid valve replacement (TVR) has been performed with mechanical or bioprosthetic valves. However, the relative advantages of the two types are incompletely known. METHODS: Between 1978 and 2003, we performed 138 TVR (35 bioprosthetic, 103 mechanical) in 125 patients (50 men, 75 women), with a mean age of 43.7 +/- 16.6 years. The diseases that required TVR were rheumatic (94), prosthetic valve failure (14), congenital (14), infective endocarditis(5), isolated tricuspid regurgitation (4), and miscellaneous conditions (7). The operations included the following: isolated TVR (41), double valve replacement (58), and triple valve replacement (39). The follow-up rate was 98.3%, and cumulative follow-up was 828.5 patient-years. RESULTS: There were 22 in-hospital deaths (17.6%) and 13 (10.4%) late deaths. Fourteen patients required additional operations. There were 33 postoperative valve-related events including 11 thromboembolisms and 3 bleeding episodes. Kaplan-Meier survival for the entire group at 15 years was 73.8 +/- 8.5% (bioprosthetic: 70.2 +/- 10.4%, mechanical: 66.0 +/- 19.4%). At 15 years, freedom from reoperation was 66.3 +/- 9.4% (bioprosthetic: 55.1 +/- 13.8%, mechanical: 86.0 +/- 6.2%) and freedom from valve-related events was 49.9 +/- 8.0%. The linearized incidence of valve thrombosis was 1.28%/patient-year (bioprosthetic: 0, mechanical: 1.92), anticoagulation-related bleeding was 0.37%/patient-year (mechanical: 0.54), reoperation was 1.71%/patient-year (bioprosthetic: 2.68, mechanical: 1.25), and valve-related events were 4.33%/patient-year (bioprosthetic: 3.83, mechanical: 4.6). CONCLUSIONS: Both bioprosthetic and mechanical valves revealed similar long-term outcomes. However, findings suggest that greater care is needed to prevent valve thrombosis in mechanical valves in the early postoperative period, and there is a greater chance for reoperation in bioprosthetic valves. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1317~1324 | - |
dc.relation.isPartOf | ANNALS OF THORACIC SURGERY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Bioprosthesis* | - |
dc.subject.MESH | Child | - |
dc.subject.MESH | Child, Preschool | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Heart Valve Prosthesis*/adverse effects | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Postoperative Complications/epidemiology | - |
dc.subject.MESH | Prosthesis Design | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Tricuspid Valve/surgery* | - |
dc.title | Long-Term Clinical Results of Tricuspid Valve Replacement | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Thoracic & Cardiovascular Surgery (흉부외과학) | - |
dc.contributor.googleauthor | Byung-Chul Chang | - |
dc.contributor.googleauthor | Sang-Hyun Lim | - |
dc.contributor.googleauthor | Gijong Yi | - |
dc.contributor.googleauthor | You Sun Hong | - |
dc.contributor.googleauthor | Sak Lee | - |
dc.contributor.googleauthor | Kyung-Jong Yoo | - |
dc.contributor.googleauthor | Meyun Shick Kang | - |
dc.contributor.googleauthor | Bum Koo Cho | - |
dc.identifier.doi | 10.1016/j.athoracsur.2005.11.005 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00016 | - |
dc.contributor.localId | A02453 | - |
dc.contributor.localId | A03366 | - |
dc.contributor.localId | A03430 | - |
dc.contributor.localId | A04421 | - |
dc.relation.journalcode | J00183 | - |
dc.identifier.eissn | 1552-6259 | - |
dc.identifier.pmid | 16564264 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0003497505019661 | - |
dc.contributor.alternativeName | Kang, Meyun Shick | - |
dc.contributor.alternativeName | Yoo, Kyung Jong | - |
dc.contributor.alternativeName | Lim, Sang Hyun | - |
dc.contributor.alternativeName | Chang, Byung Chul | - |
dc.contributor.alternativeName | Hong, You Sun | - |
dc.contributor.affiliatedAuthor | Kang, Meyun Shick | - |
dc.contributor.affiliatedAuthor | Yoo, Kyung Jong | - |
dc.contributor.affiliatedAuthor | Lim, Sang Hyun | - |
dc.contributor.affiliatedAuthor | Chang, Byung Chul | - |
dc.contributor.affiliatedAuthor | Hong, You Sun | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 81 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1317 | - |
dc.citation.endPage | 1324 | - |
dc.identifier.bibliographicCitation | ANNALS OF THORACIC SURGERY, Vol.81(4) : 1317-1324, 2006 | - |
dc.identifier.rimsid | 50571 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.